MegaRobo Raises Nearly $200M to Build Labs That AI Agents Can Call
MegaRobo Technologies, the Suzhou and Beijing based lab automation company, raised nearly $200M in a new round. The release does not name a lead or a round letter. Oman Investment Authority, the sultanate's sovereign fund, joined as a new investor alongside CMB International, and existing backers Asia Investment Capital, Granite Asia and Sinovation Ventures came back. Total raised is now about $600M; the last round was a roughly $300M Series C that made MegaRobo a unicorn in 2022. Release: https://www.prnewswire.com/news-releases/megarobo-raises-nearly-us200-million-in-new-funding-to-build-intelligence-infrastructure-for-the-physical-world-302944671.html , 36Kr: https://36kr.com/p/4075322592187524
What it does: robots plus software that run biology and chemistry experiments for pharma and biotech R&D, with more than 500 customers. The pitch changed this year. MegaRobo now calls itself intelligence infrastructure for the physical world, and the product carrying that claim is Megalaxy Lab, where a researcher or an AI agent configures an experiment, sends it to an automated lab and gets results back in machine readable form.
That last part is the interesting one. Every AI for science demo hits the same wall: the model proposes a thousand molecules and someone still has to pipette them. A lab with an API turns wet lab work into a tool call, and whoever owns that endpoint sits between the model and the real world. MegaRobo also launched Poreva Open, a protein design challenge with Tencent Cloud and Twist Bioscience that promises wet lab validation for more than 10,000 submitted sequences, a cheap way to get every protein model team to test against its labs.
The money goes to core technology, global expansion of its AI for Science business and infrastructure for AI acting in physical environments. A Gulf sovereign fund writing into a Chinese lab robotics company is its own signal: capital that wants exposure to AI for science is shopping for the physical layer, not just the models.
← Back to all articles
What it does: robots plus software that run biology and chemistry experiments for pharma and biotech R&D, with more than 500 customers. The pitch changed this year. MegaRobo now calls itself intelligence infrastructure for the physical world, and the product carrying that claim is Megalaxy Lab, where a researcher or an AI agent configures an experiment, sends it to an automated lab and gets results back in machine readable form.
That last part is the interesting one. Every AI for science demo hits the same wall: the model proposes a thousand molecules and someone still has to pipette them. A lab with an API turns wet lab work into a tool call, and whoever owns that endpoint sits between the model and the real world. MegaRobo also launched Poreva Open, a protein design challenge with Tencent Cloud and Twist Bioscience that promises wet lab validation for more than 10,000 submitted sequences, a cheap way to get every protein model team to test against its labs.
The money goes to core technology, global expansion of its AI for Science business and infrastructure for AI acting in physical environments. A Gulf sovereign fund writing into a Chinese lab robotics company is its own signal: capital that wants exposure to AI for science is shopping for the physical layer, not just the models.
Comments